Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Evaxion Biotech A/S
Scientific Title
A Phase 1/2, Study of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1 After Complete Resection of Stage IIIB/IIIC/IIID or Stage IV Melanoma in Patients at High Risk for Recurrence